Cordlife India


Cordlife Sciences India Pvt. Limited is a member of the Cordlife Group Limited family of companies. Cordlife Group Limited owns and operates five cord blood laboratories in Singapore, Hong Kong, India, Indonesia and the Philippines.

Labs and Locations

(Office) 43, Asutosh Choudhury Avenue, Sunny Towers, Kolkata 700 019, India
(Laboratory) P.L. Deuty Road, off Diamond Harbour Road Bishnupur, 24 Parganas (S) West Bengal 743503, India

Business Experience

Cordlife Group Limited is listed on the Mainboard of the Singapore Exchange (SGX), and together with its subsidiaries, may be called "The Group". Cordlife Group Limited owns five cord blood banks in Singapore, Hong Kong, Indonesia, Philippines and India, and has a direct investment in China Cord Blood Corporation, one of the top banks in China. Cordlife also currently owns over 30% of Stemlife Malaysia. At present the laboratories in Singapore, Hong Kong, and India are accredited by AABB (formerly known as American  Association of Blood Banks), meeting the gold standard of private cord blood banking. The Group now comprises of:

Cordlife Group Limited - Singapore
Cordlife (Hong Kong) Limited - Hong Kong & Macau
Cordlife Sciences India Pvt Limited - Kolkata, India
PT Cordlife Persada - Jakarta, Indonesia
Cordlife Medical Philippines, Inc. - Manila, Philippines

Cordlife Group Limited was established in Singapore in 2001 to provide a full suite of cord blood and (subsequently) tissue banking services which include the collection, processing and cryopreservation of cord blood stem cells and umbilical cord tissue. Cordlife has grown rapidly from a fledging start-up company into a multi-national corporation. In 2005, Cordlife established its first overseas cord blood processing and storage facility in Hong Kong. The ISO certified facility, with a storage capacity for 50,000 cord blood and umbilical cord units, is Hong Kong’s largest and most advanced stem cell facility. In 2011, Cordlife introduced the patented technology, CellOptima™, which is exclusively available at Cordlife in Hong Kong, to isolate two types of stem cells from umbilical cord – Epithelial stem cells and Mesenchymal Stem Cells (MSC).

Cordlife Sciences India Pvt Limited announced in April 2013 that they are the only bank in India that not only separates stem cells from cord blood and cord tissue, but also cultures them in the lab to grow an "expanded" cell count for therapeutic options.

Collection Kit

The kit contains a closed system blood bag (brand Terumo Penpol) that is pre-loaded with the anti-coagulant CPDA-1. The kit also provides the disinfectant Isopropyl alcohol swab.

Transportation Container

The collection kit contains gel packs which should be cooled before shipping. The kit is validated to maintain room temperature under test conditions.

Shipping Info:

Once we are informed of cord blood collection, our courier service team will pick up the kit for shipping at room temperature to the laboratory for processing and storage.

Processing Method

Cordlife India is the first bank in India to process cord blood with the fully automated and sterile Sepax processing system from Biosafe.

Components Stored

Parents are provided with a report describing test results for the buffy coat holding white cells and stem cells including total nucleated cells (TNC), post processing sterility, viable CD34+ counts, as well as maternal blood infectious disease results.

Storage Method

Final cord blood storage is in 25 ml blood (cryo) bag encased in an overwrap. Blood samples are kept in a quarantine freezer, then moved to long term freezer after they pass testing. Stem cells are stored in the vapour phase of cryogenic nitrogen.

Licensing & Accreditation

Certified by Drugs Controller General of India, Accredited by AABB and ISO 9001:2000.

Clinical Experience

Cordlife Group Limited has released 11 client cords for therapy (6 autologous, 5 allogeneic)


Cordlife client is covered by a guarantee that the cord blood stem cells will engraft during transplant, else the client will be provided with a matched replacement cord blood unit. Client is covered for the cost of additional tests (HLA typing and CFU assays) in the event of a transplant.
Client is covered against future payments if death or total permanent disability occurs to either parent throughout duration of storage.

Community Service

Free banking (terms and conditions apply) is given to families when a sibling has a diagnosis for which transplantation is standard therapy.
Discounts are given to for medical doctors and nurses.


Cordlife India pricing available upon enquiry.

Additional Services

Cordlife has a patent on the service of storing stem cells from the lining of the umbilical cord. This cord lining contains both Epithelial Stem Cells (EpSC) and Mesenchymal Stem Cells (MSC). Parents who are banking cord blood can choose the enhanced services CordPlus (EpSCs + MSCs) or CordBasic plan (MSCs).

Cordlife Sciences India Pvt Limited announced in April 2013 that they are the only bank in India that not only separates stem cells from cord blood and cord tissue, but also cultures them in the lab to grow an "expanded" cell count for therapeutic options.

Prices with Additional Services

Biocord, Explant, Epicord 50M and Epicord 500M